Nothing Special   »   [go: up one dir, main page]

MA53977B1 - STABLE COMPOSITIONS OF SEMAGLUTIDE AND THEIR USES - Google Patents

STABLE COMPOSITIONS OF SEMAGLUTIDE AND THEIR USES

Info

Publication number
MA53977B1
MA53977B1 MA53977A MA53977A MA53977B1 MA 53977 B1 MA53977 B1 MA 53977B1 MA 53977 A MA53977 A MA 53977A MA 53977 A MA53977 A MA 53977A MA 53977 B1 MA53977 B1 MA 53977B1
Authority
MA
Morocco
Prior art keywords
semaglutide
stable compositions
compositions
glp
histidine
Prior art date
Application number
MA53977A
Other languages
French (fr)
Other versions
MA53977A (en
Inventor
Joakim Lundqvist
Dorthe Engelund
Søren Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority claimed from PCT/EP2019/079214 external-priority patent/WO2020084126A1/en
Publication of MA53977A publication Critical patent/MA53977A/en
Publication of MA53977B1 publication Critical patent/MA53977B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des compositions pharmaceutiques de sémaglutide de peptide glp-1 comprenant un stabilisant tel que l'histidine, leur préparation, des kits comprenant de telles compositions ainsi que leurs utilisations médicales.The present invention relates to pharmaceutical compositions of glp-1 peptide semaglutide comprising a stabilizer such as histidine, their preparation, kits comprising such compositions as well as their medical uses.

MA53977A 2018-10-26 2019-10-25 STABLE COMPOSITIONS OF SEMAGLUTIDE AND THEIR USES MA53977B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18202801 2018-10-26
PCT/EP2019/079214 WO2020084126A1 (en) 2018-10-26 2019-10-25 Stable semaglutide compositions and uses thereof

Publications (2)

Publication Number Publication Date
MA53977A MA53977A (en) 2022-02-09
MA53977B1 true MA53977B1 (en) 2023-11-30

Family

ID=64051384

Family Applications (1)

Application Number Title Priority Date Filing Date
MA53977A MA53977B1 (en) 2018-10-26 2019-10-25 STABLE COMPOSITIONS OF SEMAGLUTIDE AND THEIR USES

Country Status (1)

Country Link
MA (1) MA53977B1 (en)

Also Published As

Publication number Publication date
MA53977A (en) 2022-02-09

Similar Documents

Publication Publication Date Title
MA46990B1 (en) GLP-1 COMPOSITIONS AND ITS USES
MA52492B1 (en) RIP1 INHIBITORY COMPOUNDS, METHODS OF PREPARATION AND USE THEREOF
MA40814A1 (en) Pharmaceutical compositions for combination therapy
MA44312A (en) ANTIBODIES AND THEIR METHODS OF USE
MA39094B1 (en) Combination therapy comprising an mdm2 inhibitor and one or more additional pharmaceutically active ingredients for the treatment of cancers
MX2020001403A (en) Quinoline derivatives for treating infections with helminths.
MA41072A1 (en) New pyoverine and pyochelin specific proteins
MA29378B1 (en) PHARMACEUTICAL COMPOSITION COMPRISING OMEGA-CARBOXYARYL-SUBSTITUTED DIPHENYLUREE FOR THE TREATMENT OF CANCER
UY37789A (en) NEW DERIVATIVES OF AZAQUINOLINA
SA521421715B1 (en) Stable semaglutide compositions and uses thereof
MA43409B1 (en) Polycyclic compounds for use as bruton tyrosine kinase inhibitors
MA38567A1 (en) Variants of pertuzumab and their evaluation
MA50406B1 (en) Magl pyrazole inhibitors
MA50804B1 (en) Novel bradykinin b2 receptor antagonists
MX2020011873A (en) New quinoline derivatives.
FR3063645B1 (en) ACEFAPC FOR THE TREATMENT OF ACETYLCHOLINE DEPENDENT DISEASES
MA39253B1 (en) Substituted bicyclic heteroaryl compounds used as rxr agonists
MA54318B1 (en) CAPSULE FORMULATIONS
MA53977B1 (en) STABLE COMPOSITIONS OF SEMAGLUTIDE AND THEIR USES
MX2021008071A (en) Substituted fused imidazole derivatives and methods of treating sickle cell disease and related complications.
MA53521B1 (en) New mpro protease and sars-cov2 replication inhibitor compounds, their formulations and applications
FR3065009B1 (en) BACTERIAL SECRETOME FOR USE IN THE TREATMENT OF SKIN LESIONS
MA61742A1 (en) AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI PD-1 ANTIBODY PROLGOLIMAB AND ITS USE
FR3088325B1 (en) 1,3-OXATHIOLANE-2-THIONE DERIVATIVES AND THEIR USES
FR3048361B1 (en) COMPOSITIONS FOR THE TREATMENT OF CANDIDOSES